Products

New System

05.02.2004

Ballerup - Sophion recently introduced QPatchTM 16, a 16-channel automated patch clamp system. QPatch 16 has been designed to work with voltage-gated as well as ligand-gated ion channels. Anticipated screening capability of QPatch 16 is 250 to 1200 compounds per working day. There is a further scale-up of the technology in the pipeline for 2004, offering 96 parallel patch-clamp measurements and hence six times higher throughput compared with the QPatch 16.

Clinical Trial

11.07.2010

Tübingen – A single infusion with the immune modulator cyclophosphamide before vaccination with Immatics’ multi-peptide tumour vaccine IMA901 improves response rate in patients with advanced renal cell carcinoma. 83% of the...

Clinical Trial

11.07.2010

London – It’s bad news for the European Medicines Agency. A new Eurobarometer poll (see page 10) shows that many European citizens don’t trust scientists whose work has been sponsored by industry – regardless of whether they did...

BioFunding

11.07.2010

Brussels – The European Commission has awarded EUR2.8m to a project intended to create ultra-sensitive chemical sensors and smarter, cheaper infrared (IR) photodetectors. IR-technology applications are currently expanding in...

BioFunding

11.07.2010

Brussels – The Innovative Medicines Initiative launched a EUR26m diabetes research project in mid-June. IMIDIA will focus on the factors that contribute to the functioning and survival of insulin-producing pancreatic islet cells....

Politics / Law

11.07.2010

Brussels/Geneva – Biofuel production from cheap resources such as wood waste, corn stover or grass could be the next huge market for biotech. According to estimates from the Geneva-based World Economic Forum, the market for...

Politics / Law

11.07.2010

New coexistence rules designed by the European Commission to give EU member states the right to ban acreage of genetically modified organisms (GMOs) from their territories will hamper cultivation of GMOs in Europe, say...

BioPeople

11.07.2010

Jessica Mann has been named Head of Translational Medicine at Swiss pharma giant Hoffmann-La Roche AG. Mann is leaving Swiss Evolva Holding SA, where she worked as CMO. Prior to that she was Medical Director and a board member at...

Politics / Law

11.07.2010

As the present German Insolvency Act does not provide licensees with a satisfactory solution in cases of licensor insolvency, securing Intellectual Property rights by other means needs to be a major topic for negotiations between...

Clinical Trial

10.07.2010

Basel – Roche AG has reported promising Phase III results with its anti-IL-6-antibody drug Roctrema (tocilizumab) in children with systemic juvenile idio­pathic arthritis. Following 3 months’ treatment with the immuno­modulator,...

Displaying results 271 to 280 out of 1982

< Previous 271-280 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive/browse/27/article/new-system.html

Image Gallery

Stock list

All quotes

TOP

  • RENEURON (UK)3.60 GBP13.6%
  • EPIGENOMICS (D)5.74 EUR10.4%
  • PROTHENA PLC (IE)36.95 USD9.5%

FLOP

  • CYTOS (CH)0.13 CHF-18.8%
  • XENETIC BIOSCIENCES (UK)6.00 GBP-14.3%
  • THERAMETRICS (CH)0.10 CHF-9.1%

TOP

  • BIOTECH PHARMACON (N)19.00 NOK67.4%
  • WILEX (D)0.82 EUR39.0%
  • E-THERAPEUTICS (UK)28.00 GBP34.9%

FLOP

  • CYTOS (CH)0.13 CHF-95.2%
  • BIONOR PHARMA (N)2.18 NOK-45.5%
  • DIAGENIC (N)0.78 NOK-38.1%

TOP

  • SILENCE THERAPEUTICS (UK)255.00 GBP6275.0%
  • IXICO (UK)67.00 GBP740.7%
  • PLETHORA (UK)10.62 GBP658.6%

FLOP

  • CYTOS (CH)0.13 CHF-96.8%
  • EVOCUTIS (UK)0.22 GBP-91.9%
  • ADDEX (CH)1.95 CHF-71.1%

No liability assumed, Date: 24.04.2014

Current issue

All issues

Product of the week

Products

Events

All Events

Partner-Events

München

BioVaria 2014

Frankfurt am Main

7th DVFA Life Science Conference

White Paper